{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:42Z","timestamp":1707524322186},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,28]]},"DOI":"10.7759\/cureus.31969","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T13:11:05Z","timestamp":1669641065000},"source":"Crossref","is-referenced-by-count":0,"title":["Utility of the HScore for Predicting COVID-19 Severity"],"prefix":"10.7759","author":[{"given":"William","family":"Hannah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Shadiack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Markofski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Dao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Odum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayda","family":"Parisio-Poldiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Finer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta P","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020, 395:1033-4. 10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang C","year":"2020","unstructured":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020, 55:10.1016\/j.ijantimicag.2020.105954","journal-title":"Int J Antimicrob Agents"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3560","article-title":"Early and significant reduction in c-reactive protein levels after corticosteroid therapy is associated with reduced mortality in patients with COVID-19","volume":"16","author":"Cui Z","year":"2021","unstructured":"Cui Z, Merritt Z, Assa A, et al.. Early and significant reduction in c-reactive protein levels after corticosteroid therapy is associated with reduced mortality in patients with COVID-19. J Hosp Med. 2021, 16:142-8. 10.12788\/jhm.3560","journal-title":"J Hosp Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83831-8","article-title":"Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units","volume":"11","author":"Carubbi F","year":"2021","unstructured":"Carubbi F, Salvati L, Alunno A, et al.. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units. Sci Rep. 2021, 11:10.1038\/s41598-021-83831-8","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23618","article-title":"Ferritin in the coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"34","author":"Cheng L","year":"2020","unstructured":"Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Lab Anal. 2020, 34:10.1002\/jcla.23618","journal-title":"J Clin Lab Anal"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan Q","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020, 46:846-8. 10.1007\/s00134-020-05991-x","journal-title":"Intensive Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet L","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, et al.. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014, 66:2613-20. 10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-021-2315-4","article-title":"Infection-associated hemophagocytic syndrome in critically ill patients with COVID-19","volume":"41","author":"Yang K","year":"2021","unstructured":"Yang K, Xing MY, Jiang LY, et al.. Infection-associated hemophagocytic syndrome in critically ill patients with COVID-19. Curr Med Sci. 2021, 41:39-45. 10.1007\/s11596-021-2315-4","journal-title":"Curr Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01682-y","article-title":"Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?","volume":"18","author":"Opoka-Winiarska V","year":"2020","unstructured":"Opoka-Winiarska V, Grywalska E, Roli\u0144ski J. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?. BMC Med. 2020, 18:214. 10.1186\/s12916-020-01682-y","journal-title":"BMC Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8040541","article-title":"Prevalence and outcome of secondary hemophagocytic lymphohistiocytosis among SIRS patients: results from a prospective cohort study","volume":"8","author":"Gualdoni GA","year":"2019","unstructured":"Gualdoni GA, Hofmann GA, Wohlfarth P, et al.. Prevalence and outcome of secondary hemophagocytic lymphohistiocytosis among SIRS patients: results from a prospective cohort study. J Clin Med. 2019, 8:10.3390\/jcm8040541","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee DW","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL, et al.. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014, 124:188-95. 10.1182\/blood-2014-05-552729","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023315","article-title":"Association of elevated inflammatory markers and severe COVID-19: a meta-analysis","volume":"99","author":"Ji P","year":"2020","unstructured":"Ji P, Zhu J, Zhong Z, Li H, Pang J, Li B, Zhang J. Association of elevated inflammatory markers and severe COVID-19: a meta-analysis. Medicine (Baltimore). 2020, 99:10.1097\/MD.0000000000023315","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.05.055","article-title":"Association of inflammatory markers with the severity of COVID-19: a meta-analysis","volume":"96","author":"Zeng F","year":"2020","unstructured":"Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020, 96:467-74. 10.1016\/j.ijid.2020.05.055","journal-title":"Int J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore JB","year":"2020","unstructured":"Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020, 368:473-4. 10.1126\/science.abb8925","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"26","author":"Ramos-Casals M","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet Lond Engl. 2014, 26:1503-16. 10.1016\/S0140-6736(13)61048-X","journal-title":"Lancet Lond Engl"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-207337","article-title":"Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore","volume":"75","author":"N\u00fa\u00f1ez-Torr\u00f3n C","year":"2022","unstructured":"N\u00fa\u00f1ez-Torr\u00f3n C, Ferrer-G\u00f3mez A, Moreno Moreno E, et al.. Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore. J Clin Pathol. 2022, 75:383-9. 10.1136\/jclinpath-2020-207337","journal-title":"J Clin Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218323","article-title":"Preliminary predictive criteria for COVID-19 cytokine storm","volume":"80","author":"Caricchio R","year":"2021","unstructured":"Caricchio R, Gallucci M, Dass C, et al.. Preliminary predictive criteria for COVID-19 cytokine storm. Ann Rheum Dis. 2021, 80:88-95. 10.1136\/annrheumdis-2020-218323","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16934","article-title":"Secondary HLH is uncommon in severe COVID-19","volume":"190","author":"Wood H","year":"2020","unstructured":"Wood H, Jones JR, Hui K, et al.. Secondary HLH is uncommon in severe COVID-19. Br J Haematol. 2020, 190:e283-5. 10.1111\/bjh.16934","journal-title":"Br J Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01706-0","article-title":"Assessment of the HScore as a predictor of disease outcome in patients with COVID-19","volume":"21","author":"Bordbar M","year":"2021","unstructured":"Bordbar M, Dashti AS, Amanati A, Shorafa E, Mansoori Y, Dehghani SJ, Molavi Vardanjani H. Assessment of the HScore as a predictor of disease outcome in patients with COVID-19. BMC Pulm Med. 2021, 21:338. 10.1186\/s12890-021-01706-0","journal-title":"BMC Pulm Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021, 384:693-704. 10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne JA","year":"2020","unstructured":"Sterne JA, Murthy S, Diaz JV, et al.. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020, 324:1330-41. 10.1001\/jama.2020.17023","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu X","year":"2020","unstructured":"Xu X, Han M, Li T, et al.. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020, 117:10970-5. 10.1073\/pnas.2005615117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with COVID-19","volume":"384","author":"Gordon AC","year":"2021","unstructured":"Gordon AC, Mouncey PR, Al-Beidh F, et al.. Interleukin-6 receptor antagonists in critically ill patients with COVID-19. N Engl J Med. 2021, 384:1491-502. 10.1056\/NEJMoa2100433","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/119463-utility-of-the-hscore-for-predicting-covid-19-severity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:50Z","timestamp":1707507470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/119463-utility-of-the-hscore-for-predicting-covid-19-severity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.31969","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,28]]}}}